Managing Director

Excellent track record in cutting edge science related to genetic toxicology and genetic polymorphisms of cancer, published in top notch journals. Research Professor at University of California, Berkeley and Memorial Sloan Kettering Cancer Research Center at New York. Certified in Clinical trial and data monitoring at PPD Research for selection and recruitment of patients for trials.

Managing Director

Experienced in designing and constructing major hospitals and research laboratories in addition to building commercial complexes.

Non-Executive Director

PhD from lowa State University. Worked at Bristol-Myers Squibb and NIH. Experience in drug discovery, preclinical leadership and lab animal programs. Built, operated and managed large and medium research teams/facilities and in vivo programs. In vitro, alternatives to animals and other translational Animal Models. expertise. Attended several premier leadership and management training programs.

Non-Executive Director

PhD from Columbia University, New York in electrophysiology. Served as Assistant Professor at Emory University. Extensive experience in cardiovascular research.

Non-Executive Director

A successful and serial entrepreneur founded Somahlution, Nucleonics in the past. Currently CEO of Prodigy. Served as CTO at Pfizer and headed Wyeth/Lederle Vaccine. PhD from Memorial University, Canada and postdoctorial training from Fox Chase Cancer Institute, USA.

Non-Executive Director

A successful entrepreneur, founder Femto Scientific · Somerset, New Jersey

Non-Executive Director

Currently working as Financial Controller at Vitane Pharmaceuticals Inc. Accomplished senior business manager and analyst offering experience in progressive roles in one of the world’s leading financial service companies; early career in public and private accounting. Broad-based business acumen with a blend of analytical skill and management/leadership capabilities. Received MBA in finance from Central Florida University.